BACK TO CONGRESSES

AACR Special Conference: Targeting RAS 2023

Mar 5 - 8, 2023 | Philadelphia, PA

The agents listed below are currently under investigation. Their safety and efficacy have not been established.

Presentation
KRAS-Targeted PROTAC® Degraders Are Broadly Efficacious Against KRAS Dependent Tumor Models

K Smith